ACO 253
Alternative Names: AC 253; Antam; GG 747; GR 1150747ALatest Information Update: 24 Feb 1997
At a glance
- Originator Amylin Pharmaceuticals
- Class Antihyperglycaemics
- Mechanism of Action Islet amyloid polypeptide inhibitors; Islet amyloid polypeptide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus
Most Recent Events
- 24 Feb 1997 Discontinued-I for Obesity in USA (Unknown route)
- 24 Feb 1997 Discontinued-I for Type-2 diabetes mellitus in USA (SC)
- 13 Nov 1995 Phase-I clinical trials for Obesity in USA (Unknown route)